Ubrelvy (ubrogepant) is manufactured by AbbVie Inc., a global biopharmaceutical company [1]. AbbVie is headquartered in North Chicago, Illinois [1].
What is Ubrelvy used for?
Ubrelvy is a prescription medication used for the acute treatment of migraine with or without aura in adults [2]. It is a gepant, a class of drugs that block the activity of calcitonin gene-related peptide (CGRP), a molecule involved in migraine pain [3].
How does Ubrelvy work?
Ubrelvy works by blocking the action of CGRP, a substance in the body that is thought to play a role in migraine headaches [3]. By inhibiting CGRP, Ubrelvy helps to reduce migraine pain and other symptoms [3].
When did Ubrelvy become available?
Ubrelvy was approved by the U.S. Food and Drug Administration (FDA) in December 2019 [2].
Who else makes migraine treatments?
Several pharmaceutical companies develop and market treatments for migraine. Beyond AbbVie, other notable manufacturers include:
* Eli Lilly and Company: Produces Emgality (galcanezumab-gnlm), another CGRP-targeting medication [4].
* Biohaven Pharmaceuticals (now part of Pfizer): Developed Nurtec ODT (rimegepant), a dual-acting CGRP antagonist [5].
* Teva Pharmaceuticals: Offers Ajovy (fremanezumab-vfrm), another CGRP inhibitor [6].
This competitive landscape means patients have various options for migraine management.
What is the difference between Ubrelvy and Nurtec ODT?
Both Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) are oral medications approved for the acute treatment of migraine and belong to the gepant class of drugs that target CGRP [5][2]. The primary difference lies in their indications and administration. While both are used for acute migraine treatment, Nurtec ODT is also approved for the preventive treatment of episodic migraine [5]. Ubrelvy is taken with or without food, whereas Nurtec ODT is a dissolvable oral tablet that can be taken with or without water [2][5].
What are the potential side effects of Ubrelvy?
The most common side effects reported with Ubrelvy include nausea, diarrhea, and decreased positive test results for SARS-CoV-2 (which can be related to testing for COVID-19) [2]. Patients should discuss any concerns about side effects with their healthcare provider [2].
Are there patent protections for Ubrelvy?
Yes, Ubrelvy is protected by patents. Information on patent expiry dates and any associated litigation can often be found through specialized patent tracking resources, such as DrugPatentWatch.com [7].
What are the clinical trial results for Ubrelvy?
Clinical trials for Ubrelvy demonstrated its efficacy in treating migraine [2]. Key endpoints typically assessed in these trials include pain freedom and absence of the most bothersome migraine-associated symptom at two hours post-dose [2]. These trials form the basis for its FDA approval [2].
What patient concerns exist regarding Ubrelvy?
Patient concerns may revolve around treatment effectiveness, potential side effects, cost, and insurance coverage for Ubrelvy [2]. As with any medication, individual responses can vary, and consulting with a healthcare professional is crucial for personalized guidance.
Can Ubrelvy be used for migraine prevention?
Ubrelvy is indicated for the acute treatment of migraine and is not approved for migraine prevention [2]. Other CGRP-targeting medications, like Nurtec ODT and Aimovig, are approved for preventive treatment [5][4].
---
Sources:
1. https://www.abbvie.com/
2. https://www.ubrelvy.com/
3. https://www.drugpatentwatch.com/blog/what-are-gepants-and-how-do-they-work-for-migraine
4. https://www.myemgality.com/
5. https://www.nurtec-otd.com/
6. https://www.ajovy.com/
7. https://www.drugpatentwatch.com/